홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

디사이클로베린

Dicyclomine

HCID 3042
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
67-92-5
표준 SMILES
CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1
InChIKey
CURUTKGFNZGFSE-UHFFFAOYSA-N
분자식
C19H35NO2
평균 분자량
309.5 g/mol
단동위원소 질량
309.26677936

개요

Dicyclomine is the ester resulting from the formal condensation of 1-cyclohexylcyclohexanecarboxylic acid with 2-(diethylamino)ethanol. An anticholinergic, it is used as the hydrochloride to treat or prevent spasm in the muscles of the gastrointestinal tract, particularly that associated with irritable bowel syndrome. It has a role as a muscarinic antagonist, a parasympatholytic and an antispasmodic drug. It is a tertiary amine and a carboxylic ester. It is functionally related to a 2-diethylaminoethanol and a 1,1'-bi(cyclohexyl)-1-carboxylic acid.

이름 및 식별자

우선 이름
Dicyclomine
IUPAC
2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate
현지명
디사이클로베린
영어명
dicycloverine
분자식
C19H35NO2
분자량
309.49

이름 및 동의어

dicyclomineDicycloverineDicycloverin77-19-0DiocylDicicloverinaDicycloverinumDicymine2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylateDTXSID10229264KV4X8IF6V(Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester
이름 더 보기
디사이클로베린C06951WyovinicyclomineDicycloverine-D3,D4Dicycloverine (Dicyclomine)1,1'-Bicyclohexane-1-carboxylic acid 2-(diethylamino)ethyl
[1,1'-Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate(1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester2-diethylaminoethyl 1-cyclohexylcyclohexane-1-carboxylateBicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl esterCHEBI:4514DTXCID002926[Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester

데이터베이스 식별자

CAS
67-92-5、77-19-0
PubChem CID
3042
DTXSID

물성

구조 계산 물성

XLogP
5.5
극성 표면적
29.5 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
3
회전 가능 결합 수
8
무거운 원자 수
22
형식 전하
0
복잡도
326

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

LogP5.5
Solubility · 3건

SOL IN WATER ABOUT 25% /HYDROCHLORIDE/

1 G IN 13 ML WATER, 5 ML ALC, 2.5 ML CHLOROFORM, 770 ML ETHER; INSOL IN ALKALINE AQ MEDIUM /HCL/

3.27e-03 g/L

Human DrugsBreast Feeding; Lactation; Milk, Human; Muscarinic Antagonists; Parasympatholytics
Melting Point165-166
Physical DescriptionSolid
Stability/Shelf LifeSTABLE IN AIR & TO MODERATE HEAT /HYDROCHLORIDE/
Collision Cross Section179.29 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Other Experimental Properties · 4건

MP 164-166 °C /HYDROCHLORIDE/

PRACTICALLY ODORLESS & HAS VERY BITTER TASTE /HYDROCHLORIDE/

CRYSTALS FROM BUTANONE /HYDROCHLORIDE/

FINE, WHITE, CRYSTALLINE POWDER /HYDROCHLORIDE/

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Regulatory InformationREACH registered substance: Dicycloverine (EC: 201-009-4)
Other Safety InformationIMAP assessments - [1,1'-Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

독성 정보

Interactions...ANTICHOLINERGIC AGENTS, SUCH AS...DICYCLOMINE...WOULD BE EXPECTED TO INTERACT WITH DIGOXIN...
HepatotoxicityLike other anticholinergic agents, dicyclomine has not been linked to episodes of liver enzyme elevations or clinically apparent liver injury. The metabolism of dicyclomine is not well defined but it is likely metabolized by the liver.
Human Toxicity Excerpts · 3건

SIDE EFFECTS OF DICYCLOMINE INCL DIZZINESS, FEELING OF ABDOMINAL FULLNESS, & DRY MOUTH. CONSTIPATION, BLURRED VISION, FATIGUE, SEDATION, NAUSEA, VOMITING, HEADACHE, IMPOTENCE, URINARY RETENTION, & RASH OCCUR RARELY.

THERE IS ONE REPORT THAT WHEN PT UNDER TREATMENT FOR GLAUCOMA OF UNSPECIFIED TYPE WERE GIVEN 10 MG OF DICYCLOVERINE HYDROCHLORIDE ORALLY, THEY HAD RISE OF 3-10 MM HG FOR 2-3 HR. IN MOST CASES NO RISE OF OCULAR PRESSURE HAS BEEN FOUND, REGARDLESS OF TYPE OF GLAUCOMA. /HYDROCHLORIDE/

화학 및 산업

약리 정보

ATC Code · 2건

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein BindingData regarding plasma protein binding of dicyclomine is not readily available.
Pharmacodynamics · 1건

Dicyclomine is an anticholinergic drug used to relax the smooth muscles of the intestines. It's duration of action is not especially long as it is usually taken 4 times daily with individual doses of 20-40mg orally or 10-20mg by intramuscular injection. Dicyclomine should not be administered intravenously.

Mechanism of Action · 2건

Dicyclomine achieves its action partially through direct antimuscarinic activity of the M1, M3, and M2 receptors; and partially through antagonism of bradykinin and histamine. Dicyclomine non-competitively inhibits the action of bradykinin and histamine, resulting in direct action on the smooth muscle, and decreased strength of contractions seen in spasms of the ileum.

...MAJOR ACTION APPEARS TO BE NONSPECIFIC DIRECT RELAXANT ACTION ON SMOOTH MUSLCE RATHER THAN COMPETITIVE ANTAGONISM OF ACH.

Biological Half-LifeThe mean plasma elimination half life is approximately 1.8 hours.
Metabolism/MetabolitesThe metabolism of dicyclomine has not been well researched.
FDA Pharmacological Classification · 5건

4KV4X8IF6V

DICYCLOMINE

Established Pharmacologic Class [EPC] - Anticholinergic

Mechanisms of Action [MoA] - Cholinergic Antagonists

Dicyclomine is an Anticholinergic. The mechanism of action of dicyclomine is as a Cholinergic Antagonist.

MeSH Pharmacological Classification · 2건

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
DTXSID1022926
ChEMBL
CHEMBL1123
ChEBI
CHEBI:4514
UNII
4KV4X8IF6V
EC Number
201-009-4
Nikkaji
J4.195E

물리화학적 성질

끓는 점
142 · 142-143 °C(Press: 0.5 Torr)
밀도
0.99 · 0.990±0.06 g/cm3(Predicted)
산도 계수 (pKa)
9.24 · 9.24±0.25(Predicted)
EPA
1 · [1,1'-Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester (77-19-0)

INCIDENCE OF BIRTH DEFECTS IN OFFSPRING OF WOMEN WHO TOOK BENDECTIN CONTAINING 10 MG DICYCLOMINE HCL DURING PREGNANCY WAS INVESTIGATED. BIRTHS WERE TRACED FOR 2,298 PT & INCIDENCE OF DEFECTS COMPARED WITH THOSE IN RELEVANT POPULATIONS. NO EVIDENCE OF TERATOGENICITY FOUND.

Drug Induced Liver Injury · 5건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

dicyclomine

DILI Negative

Oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
EPA Human Health Benchmarks for Pharmaceuticals · 6건

Dicyclomine

1.9

7.9

The recommended initial dose is 20 mg four times a day. After one week treatment with the initial dose, the dose may be increased to 40 mg four times a day unless side effects limit dosage escalation.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 80 mg/day, Lowest Therapeutic Dose (LTD): 1.0 mg/kg-day, and Screening Dose: 0.0003 mg/kg-day.

31-May-18

안전 데이터

tsca
TSCA listed
유해 물질 데이터
77-19-0(Hazardous Substances Data)

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.

Absorption, Distribution and Excretion · 4건

The bioavailability of dicyclomine has not been determined, though it is likely well absorbed as the primary route of elimination is in the urine. Dicyclomine has a Tmax of 1-1.5h.

Dicyclomine is 79.5% eliminated in the urine and 8.4% in the feces.

The volume of distribution for a 20mg oral dose is 3.65L/kg.

Data regarding the clearance of dicyclomine is not readily available.

Cellular LocationsMembrane

용도 및 제조

Uses · 2건

MEDICATION

Use (kg) in USA (2002): 2250

Methods of Manufacturing · 2건

US PATENT 2,474,796. /HYDROCHLORIDE/

PREPD FROM 1-CYCLOHEXYLCYCLOHEXYL CYANIDE BY ALCOHOLYSIS & ESTERIFICATION... /HYDROCHLORIDE/

Formulations/PreparationsDICYCLOMINE HYDROCHLORIDE, USP, BENTYL; CAPSULES: 10 MG; TABLETS: 20 MG; SYRUP: 2 MG/ML, 10 TO 20 MG. ALSO AVAILABLE IN SOLN OR AS POWDER FOR DISSOLUTION FOR INJECTION. /HYDROCHLORIDE/
General Manufacturing Information[1,1'-Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester: INACTIVE

응용 분야

용도Anticholinergic.

상·하류 제품 정보

상류 원료

황산나트륨수소에틸알코올

공급사9 곳

北京华美互利生物化工010-56205725 · [email protected]
銳迪國際科技有限公司18024082417 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
河南天孚化工有限公司+86-0371-55170693 +86-19937530512 · [email protected]
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.+8618950047208 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
南京世洲生物科技有限公司17301488900 · [email protected]
추가 설명 · 1건

정의ChEBI: The ester resulting from the formal condensation of 1-cyclohexylcyclohexanecarboxylic acid with 2-(diethylamino)ethanol. An anticholinergic, it is used as the hydrochloride to treat or prevent spasm in the muscles of the gastrointestinal tract, particularl that associated with irritable bowel syndrome.